Seres Therapeutics, Inc. - COMMON STOCK (MCRB)

CUSIP: 81750R201

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
8,667,871
Total 13F shares
2,441,565
Share change
+313,685
Total reported value
$36,368,373
Put/Call ratio
73%
Price per share
$14.88
Number of holders
35
Value change
+$4,536,402
Number of buys
21
Number of sells
12

Security key

81750R201

Report period

Q4 2025

Institutions

35

Top holders

10

Ownership snapshot

Top shareholders of MCRB - Seres Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
FMR LLC
13D/G signal
FMR LLC
Evidence rows
49
Latest as of
30 Sep 2025
13D/G 13F 3/4/5 Lead comparable stake: 3.1% 13D/G row: FMR LLC Showing first 8 of 49 holder rows. Open remaining rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13D/G 13F
Company
3.1%
$3,377,609
268,704 shares
-$2,827,043 30 Jun 2025
Flagship Pioneering, LLC
13F
Company
13F
13%
$22,238,554
1,155,850 shares
30 Sep 2025
VANGUARD GROUP INC
13F
Company
13F
3.6%
$6,000,745
311,889 shares
30 Sep 2025
MARSHALL WACE, LLP
13F
Company
13F
1.4%
$2,416,543
125,600 shares
30 Sep 2025
BlackRock, Inc.
13F
Company
13F
1.2%
$1,963,635
102,060 shares
30 Sep 2025
Vontobel Holding Ltd.
13F
Company
13F
1.1%
$1,895,352
98,511 shares
30 Sep 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.98%
$1,635,753
84,982 shares
30 Sep 2025
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
13F
0.36%
$604,194
31,403 shares
30 Sep 2025
Show 41 additional holder rows in the full holder list
Holder Evidence Ownership % Position 12M Net Δ As of
CITADEL ADVISORS LLC
13F
Company
13F
0.36%
$594,227
30,885 shares
30 Sep 2025
STATE STREET CORP
13F
Company
13F
0.34%
$572,024
29,731 shares
30 Sep 2025
Schonfeld Strategic Advisors LLC
13F
Company
13F
0.33%
$556,843
28,942 shares
30 Sep 2025
Lion Point Capital, LP
13F
Company
13F
0.31%
$522,135
27,138 shares
30 Sep 2025
J. Goldman & Co LP
13F
Company
13F
0.31%
$519,480
27,000 shares
30 Sep 2025
MORGAN STANLEY
13F
Company
13F
0.21%
$352,746
18,334 shares
30 Sep 2025
UBS Group AG
13F
Company
13F
0.15%
$244,002
12,682 shares
30 Sep 2025
NORTHERN TRUST CORP
13F
Company
13F
0.14%
$232,824
12,101 shares
30 Sep 2025
Invesco Ltd.
13F
Company
13F
0.12%
$200,904
10,442 shares
30 Sep 2025
BANK OF AMERICA CORP /DE/
13F
Company
13F
0.06%
$102,799
5,343 shares
30 Sep 2025
SBI Securities Co., Ltd.
13F
Company
13F
0.04%
$66,994
3,482 shares
30 Sep 2025
SIMPLEX TRADING, LLC
13F
Company
13F
0.03%
$54,000
2,807 shares
30 Sep 2025
CITIGROUP INC
13F
Company
13F
0.03%
$50,428
2,621 shares
30 Sep 2025
BARCLAYS PLC
13F
Company
13F
0.02%
$27,090
1,408 shares
30 Sep 2025
ROYAL BANK OF CANADA
13F
Company
13F
0%
$6,000
287 shares
30 Sep 2025
BNP PARIBAS FINANCIAL MARKETS
13F
Company
13F
0%
$4,079
212 shares
30 Sep 2025
Physician Wealth Advisors, Inc.
13F
Company
13F
0%
$2,733
142 shares
30 Sep 2025
JPMORGAN CHASE & CO
13F
Company
13F
0%
$1,251
65 shares
30 Sep 2025
US BANCORP \DE\
13F
Company
13F
0%
$231
12 shares
30 Sep 2025
WELLS FARGO & COMPANY/MN
13F
Company
13F
0%
$192
10 shares
30 Sep 2025
Sound Income Strategies, LLC
13F
Company
13F
0%
$156
8 shares
30 Sep 2025
OSAIC HOLDINGS, INC.
13F
Company
13F
0%
$151
8 shares
30 Sep 2025
Federation Des Caisses Desjardins du Quebec
13F
Individual
13F
0%
$58
3 shares
30 Sep 2025
Arax Advisory Partners
13F
Company
13F
0%
$38
2 shares
30 Sep 2025
Nutritional Health LTP Fund General Partner LLC
3/4/5
10%+ Owner
class O/S missing
$31,715,635
23,493,063 shares
05 Jul 2022
NESTLE SA
3/4/5
10%+ Owner
class O/S missing
$18,378,993
21,879,753 shares
30 Sep 2024
Flagship Pioneering Fund VII General Partner LLC
3/4/5
10%+ Owner
class O/S missing
$7,864,418
5,825,495 shares
05 Jul 2022
David Arkowitz
3/4/5
Chief Financial Officer
mixed-class rows
$240,068
502,222 shares
mixed-class rows
14 Feb 2024
David S. Ege
3/4/5
Executive Vice President and Chief Technology Officer
mixed-class rows
$97,342
395,168 shares
mixed-class rows
15 Aug 2024
Paula Cloghessy
3/4/5
Executive Vice President, Chief People Officer
mixed-class rows
$71,843
150,101 shares
mixed-class rows
27 Oct 2023
Lisa von Moltke
3/4/5
Executive Vice President and Chief Medical Officer
mixed-class rows
$46,765
716,593 shares
mixed-class rows
15 Feb 2025
Meryl Zausner
3/4/5
Director
class O/S missing
$42,857
31,746 shares
05 Jul 2022
Hans-Juergen Woerle
3/4/5
Director
class O/S missing
120,000 shares
04 Feb 2025
Kurt Graves
3/4/5
Director
class O/S missing
100,000 shares
10 Apr 2025
Paul Biondi
3/4/5
Director
class O/S missing
100,000 shares
10 Apr 2025
Willard H. Dere
3/4/5
Director
class O/S missing
100,000 shares
10 Apr 2025
Gregory Behar
3/4/5
Director
class O/S missing
35,000 shares
22 Jun 2023
Stephen Berenson
3/4/5
Director
class O/S missing
11,470 shares
01 Jul 2025
Robert L. Rosiello
3/4/5
Director
class O/S missing
10,000 shares
05 Aug 2025
Claire Fraser
3/4/5
Director
class O/S missing
6,452 shares
01 Jul 2025
Dennis A. Ausiello
3/4/5
Director
class O/S missing
6,452 shares
01 Jul 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
35
Shares
2,441,565
Rows loaded
35
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
32
Q4 2025 holders
35
Holder diff
3
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .